Glenmark Pharmaceuticals board to consider financial statements

23 Jul 2012 Evaluate
Glenmark Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 02, 2012 to consider and approve the company’s unaudited financial statements for the quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Glenmark Pharma Share Price

1626.55 -15.00 (-0.91%)
08-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.30
Dr. Reddys Lab 1370.60
Cipla 1495.05
Lupin 2252.40
Zydus Lifesciences 981.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.